Study subjects
| . | Prespecified comparison groups . | All subjects . | ||
|---|---|---|---|---|
| HIV+ . | HIV− . | HIV+ . | HIV− . | |
| n | 15 | 9 | 19 | 18 |
| Age, y | 46 (35-58) | 46 (29-65) | 46 (35-58) | 50 (29-68) |
| Sex, no. (%) | ||||
| Male | 15 (100) | 9 (100) | 19 (100) | 18 (100) |
| Female | 0 | 0 | 0 | 0 |
| Race, no. (%) | ||||
| Black | 5 (33) | 4 (44) | 9 (50) | 6 (33) |
| Native American | 1 (7) | 2 (22) | 1 (5) | 3 (17) |
| Asian | 1 (7) | 1 (11) | 1 (5) | 1 (6) |
| White | 8 (53) | 2 (22) | 8 (42) | 8 (44) |
| Hispanic | 3 (22) | 0 (0) | 3 (16) | 2 (11) |
| MSM (ever) | 14 (93) | 7 (78) | 17 (89) | 15 (83) |
| IVDU (ever) | 1 (7) | 0 (0) | 1 (5) | 0 (0) |
| Pet at home | 3 (20) | 3 (33) | 3 (16) | 5 (28) |
| Child under age 10 at home | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| CD4 count/μL (median, range) | 260 (54-388) | 1203 (749-1990) | 244 (18-392) | 1060 (326-1990) |
| HIV VL/mL (median, range) | 44 000 (135-382 000) | NA | 46 000 (135-382 000) | NA |
| History of ART, no. (%) | 2 (13) | NA | 2 (11) | NA |
| Serologies, no. (%) | ||||
| EBV VCA IgG+ | 8 (53) | 4 (44) | 10 (53) | 6 (33) |
| H pylori IgG+ | 6 (40) | 5 (56) | 8 (42) | 11 (61) |
| CMV IgG+ | 15 (100) | 9 (100) | 19 (100) | 12 (68)* |
| HCV IgG+ with negative HCV viral load | 0 (0) | 0 (0) | 1 (5) | 2 (11) |
| Nucleic acid tests, no. (%) | ||||
| HCV | 0 (0) | 0 (0) | 0 (0) | 1 (6) |
| HBV | 0 (0) | 0 (0) | 3 (16) | 1 (6) |
| . | Prespecified comparison groups . | All subjects . | ||
|---|---|---|---|---|
| HIV+ . | HIV− . | HIV+ . | HIV− . | |
| n | 15 | 9 | 19 | 18 |
| Age, y | 46 (35-58) | 46 (29-65) | 46 (35-58) | 50 (29-68) |
| Sex, no. (%) | ||||
| Male | 15 (100) | 9 (100) | 19 (100) | 18 (100) |
| Female | 0 | 0 | 0 | 0 |
| Race, no. (%) | ||||
| Black | 5 (33) | 4 (44) | 9 (50) | 6 (33) |
| Native American | 1 (7) | 2 (22) | 1 (5) | 3 (17) |
| Asian | 1 (7) | 1 (11) | 1 (5) | 1 (6) |
| White | 8 (53) | 2 (22) | 8 (42) | 8 (44) |
| Hispanic | 3 (22) | 0 (0) | 3 (16) | 2 (11) |
| MSM (ever) | 14 (93) | 7 (78) | 17 (89) | 15 (83) |
| IVDU (ever) | 1 (7) | 0 (0) | 1 (5) | 0 (0) |
| Pet at home | 3 (20) | 3 (33) | 3 (16) | 5 (28) |
| Child under age 10 at home | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| CD4 count/μL (median, range) | 260 (54-388) | 1203 (749-1990) | 244 (18-392) | 1060 (326-1990) |
| HIV VL/mL (median, range) | 44 000 (135-382 000) | NA | 46 000 (135-382 000) | NA |
| History of ART, no. (%) | 2 (13) | NA | 2 (11) | NA |
| Serologies, no. (%) | ||||
| EBV VCA IgG+ | 8 (53) | 4 (44) | 10 (53) | 6 (33) |
| H pylori IgG+ | 6 (40) | 5 (56) | 8 (42) | 11 (61) |
| CMV IgG+ | 15 (100) | 9 (100) | 19 (100) | 12 (68)* |
| HCV IgG+ with negative HCV viral load | 0 (0) | 0 (0) | 1 (5) | 2 (11) |
| Nucleic acid tests, no. (%) | ||||
| HCV | 0 (0) | 0 (0) | 0 (0) | 1 (6) |
| HBV | 0 (0) | 0 (0) | 3 (16) | 1 (6) |
MSM indicates men who have sex with men; IVDU, intravenous drug use; and NA, not applicable.
P < .05.